Evaluation of fractional erbium: YAG laser and glycolic acid 70% peeling in melasma improvement

https://doi.org/10.53730/ijhs.v6nS3.5687

Authors

  • Hesham Aly Shokeir Professor of Laser Applications in Dermatology, National Institute Of Laser Enhanced Sciences Niles (NILE), Cairo University, Egypt
  • Wafaa Mohammad Ramadan Faculty of Medicine, Tanta University, Egypt
  • Maha Rafie Abo Eittah Assistant Professor of Laser Applications in Dermatology, National Institute Of Laser Enhanced Sciences Niles (NILE), Cairo University, Egypt
  • Noura Abdel Moneim El Seessy Master Degree of dermatology and Venereology, Assistant lecture of dermatology- Faculty of Medicine- kafr El Sheik University, Egypt

Keywords:

chemical peeling, erbium YAG laser, glycolic acid, Melasma

Abstract

Melasma is an acquired chronic hyperpigmentation which mainly affects women on sun-exposed areas of the body, especially on the face in Fitzpatrick skin types III-V. The study setting is at the Dermatology Clinic at NILES, Cairo University, Egypt. This study aims to evaluate the clinical efficacy and safety of fractional ablative erbium:YAG Laser therapy versus chemical peeling in treatment of melasma. This study included 30 patients with melasma on their face aged 20-50 years. The patients were divided into two groups. In group I, 15 patients were treated by four sessions of fractional erbium YAG laser at 4 weeks interval. In group II, 15 patients were treated by four sessions of chemical peeling with glycolic acid 70%.The percentage of improvement in patients treated by fractional erbium YAG laser was 20 – 80% with amean 54.33 ± 18.01 and the percentage of improvement in patients treated by chemical peeling was 30 – 85 % with a mean 53.33 ± 18.09. So, there was no significant difference in the percentage of improvement in both groups (P- value = 0.881). It was observed that fractional erbium YAG is as effective as 70% glycolic acid peel in patients with melasma.

Downloads

Download data is not yet available.

References

Pawaskar MD, Parikh P, Markowski T, Mc Michael AJ, Feldman SR, Balkrishan R (2007) Melasma and its impact on health related QOL in Hispanic women. J Dermatolog Treat 18:5-9.

Arora P, Sarkar R, Garg VK, Arya L (2012) Lasers for treatment of melasma and post-inflammatory hyperpigmentation. J Cutan Aesthet Surg 5 (2): 93-103.

Puri N and Puri A (2013) A study on fractional erbium glass laser therapy versus chemical peeling for treatment of melasma in female patients. J Cutan Aesthet Surg 6(3):148 – 151.

Kang WH, Yooh KH, Lee ES, Kim J, Lee KB, Yim H, et al (2002) Melasma: Histopathological characteristics in 56 korean patients. Br J Dermatol 146: 228- 237.

Rokhsar CK and Fitzpatrick RE (2005) The treatment of melasma with fractional photothermolysis: A pilot study. Dermatol Surg 31: 1645 – 1650.

Wanitphakdeedech R, Manuskiatti W, Siriphukpong S, Chen TM (2009) Treatnent of melasma using variable square pulse Er:YAG laser resurfacing. Dermatol Surg 35:475-481.

Morais OO, Lemos EF, Sousa MC, Gomes CM, Costa IM, Paula CD (2013) The use of ablative lasers in the treatment of facial melasma. An. Bras. Dermatol. 88:590 – 596.

Handel AC, Miot LD, Miot HA (2014) Melasma: a clinical and epidemiological review. An Bras Dermatol. 89(5):771–82.

Miot HA, Miot LD (2009) Re: Topical 10% zinc sulfate solution for treatment of melasma. Dermatol Surg. 35:2050-1.

Lakhdar H, Zouhair K, Khadir K, Essari A, Richard A, Seite S, et al (2007) Evaluation of the effectiveness of a broad-spectrum sunscreen in the prevention of chloasma in pregnant women. J Eur Acad Dermatol Venereol. 21:738-42.

Manaloto RM, Alster T (1999) Erbium:YAG laser resurfacing for refractory melasma.Dermatol Surg. 25(2):121-3.

Sarkar R, Chugh S, Garg VK (2012) Newer and upcoming therapies for melasma. Indian J Dermatol Venereol Leprol. 78(4):417-28.

Lee BW, Schwartz RA, Janniger CK. Melasma (2017) G Ital Dermatol Venereol. 152(1):36-45.

Bandyopadhyay D. TOPICAL TREATMENT OF MELASMAIndian J Dermatol. 2009; 54(4): 303–309.

Lee MW. Combination 532-nm and 1064-nm lasers for noninvasive skin rejuvenation and toning. Arch Dermatol. 2003; 139:1265–76.

Tamler C, Fonseca RM, Pereina FB and Barcani CB (2009) Classification of melasma by dermoscopy: comparative study with Wood’s lamp.Surgical & Cosmetic Dermatology 1(3):115-119

Hammerschmidt M, Mattos SM, Freitas CF, and Mukal MM (2012) Evaluation of melasma classification methods based on response to treatment. Surg Cosmet Dermatol 4(2):155-8.

Katz TM, Glaich AS, Goldberg LH, Firoz BF, Dai T, Friedman PM (2010) Treatment of melasma using fractional photothermolysis: A report of eight cases with long-term follow-up. Dermatol Surg. 36:1273–80.

Park GH, Chang SE, Bang S, Won KH, Won KH, Won CH, Lee MW et al (2015) Usefulness of Skin Explants for Histologic Analysis after Fractional Photothermolysis. Ann Dermatol. 27(3): 283–290.

Sheth VM, Pandya AG (2011) Melasma: a comprehensive update: part II. J Am Acad Dermatol. 65:699-714.

Sardesai VR, Kolte JN, Srinivas BN (2013) A clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment. Indian J Dermatol. 58:239.

Sharad J (2013) Glycolic acid peel therapy – a current review. Clinical, Cosmetic and Investigational Dermatology 6:281–288.

Published

08-04-2022

How to Cite

Shokeir, H. A., Ramadan, W. M., Eittah, M. R. A., & Seessy, N. A. M. E. (2022). Evaluation of fractional erbium: YAG laser and glycolic acid 70% peeling in melasma improvement. International Journal of Health Sciences, 6(S3), 1554–1563. https://doi.org/10.53730/ijhs.v6nS3.5687

Issue

Section

Peer Review Articles